Back to today’s briefing

Story perspectives

FDA Rehires Laid-Off Staff to Boost Drug Safety

5/3/2025

46 11

Summary

Story summary

In a significant turnaround, the FDA has welcomed back former employees who were laid off during extensive cuts, particularly in its Freedom of Information Act divisions. This decision aims to restore clarity in drug safety monitoring, which had suffered from the layoffs, as the agency grapples with the critical balance of transparency and safety amid ongoing changes.

1 of 1

Story summary

In a significant turnaround, the FDA has welcomed back former employees who were laid off during extensive cuts, particularly in its Freedom of Information Act divisions. This decision aims to restore clarity in drug safety monitoring, which had suffered from the layoffs, as the agency grapples with the critical balance of transparency and safety amid ongoing changes.